Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Intensive Palliative Care For Patients With Hematological Cancer Dying In Hospice

B. Cheng, M. Sham, Kwok Ying Chan, C. W. Li, Ho Yan Au
Published 2015 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Dying of hematological oncology patients often take place in respective hematology ward or intensive care unit rather than hospice. With the increased attention to quality palliative care for hematology patients, concerns regarding their level of medical care at end-of-life need to be addressed. We conducted a retrospective review of consecutive hematological oncology patients who succumbed in a palliative unit between July 2012 and August 2013. The primary outcome measure was their level of medical care received, including administration of antibiotics, total parenteral nutrition, blood sampling, GCSF injection and blood products transfusion, during their last seven days of life. During the last seven days of life, 85.7 % of patients had blood sampling and 23.8% of patients received G-CSF injection. Total parenteral nutrition was administered in 14.3% of patients. One-third of patients received transfusion of packed cells and nearly half of them received transfusion of platelet concentrates. Almost 90% of patients received antibiotics during their last week of life. Collaboration between hematology and palliative care has resulted in successful transition of hematologic cancer patients into hospice unit in their terminal phase of illness. However, their level of medical care, even approaching last seven days of life, remained intensive. Proper allocation of medical resources and future research regarding optimal end-of-life care for hematology patients are warranted.
This paper references
10.2147/CIA.S35082
Management of mantle cell lymphoma in the elderly patient
J. Doorduijn (2013)
Infections in haematologic neoplasms: autopsy findings.
A. Nosari (1991)
10.1111/j.1445-5994.2003.00490.x
Australasian haematologist referral patterns to palliative care: lack of consensus on when and why
K. Auret (2003)
10.1016/j.jpainsymman.2012.09.010
A nationwide analysis of antibiotic use in hospice care in the final week of life.
J. Albrecht (2013)
10.1016/j.jpainsymman.2013.10.007
Emergence of vancomycin-resistant enterococci in the palliative care setting-how to strike the right balance in infection control measures?
Hon Wai Benjamin Cheng (2014)
10.1097/PPO.0b013e3181f842b3
Invasive Palliative Interventions: When Are They Worth It and When Are They Not?
F. Strasser (2010)
10.1111/j.1537-2995.2012.03658.x
How do I allocate blood products at the end of life? An ethical analysis with suggested guidelines
L. Smith (2013)
10.1016/S0885-3924(03)00040-X
Antimicrobial use in patients with advanced cancer receiving hospice care.
P. H. White (2003)
10.1007/s00520-012-1417-8
Dying of hematologic patients—treatment characteristics in a German University Hospital
P. Brueck (2012)
10.1007/s005209900087
Characteristics of deaths in a department of oncohaematology within a general hospital
F. Bauduer (2000)
10.1111/J.1365-2354.2006.00745.X
Special considerations for haematology patients in relation to end-of-life care: Australian findings.
P. Mcgrath (2007)
10.1016/J.JPAINSYMMAN.2005.03.006
Symptomatic treatment of infections in patients with advanced cancer receiving hospice care.
R. Reinbolt (2005)
10.1191/0269216302pm571oa
The coverage of cancer patients by designated palliative services: a population-based study, South Australia, 1999
R. Hunt (2002)
10.1089/JPM.2005.8.1025
Interval between palliative care referral and death among patients treated at a comprehensive cancer center.
W. Cheng (2005)
10.1089/jpm.2009.0267
Palliative care and the hemato-oncological patient: can we live together? A review of the literature.
Vanessa J. Manitta (2010)
Characteristics of deaths in a department of oncohaematology from a general hospital: a study of 81 cases
F Bauder (2000)
10.1200/JCO.2002.08.138
Place of death and its predictors for local patients registered at a comprehensive cancer center.
E. Bruera (2002)
10.1089/jpm.2012.0377
Palliative care and hematological malignancies: increased referrals at a comprehensive cancer centre.
C. L. Corbett (2013)
10.1177/104990910201900208
Qualitative findings on the experience of end-of-life care for hematological malignancies
P. Mcgrath (2002)
10.1056/NEJMoa1200920
Treatment of older patients with mantle-cell lymphoma.
H. Kluin-Nelemans (2012)
10.1136/jcp.30.8.782-c
International Classification of Diseases for Oncology
P. Trott (1977)



This paper is referenced by
10.1177/0269216317735246
Palliative care in patients with haematological neoplasms: An integrative systematic review
Deborah Moreno-Alonso (2018)
10.1111/ajco.12701
Patterns of health services utilization in the last two weeks of life among cancer patients: Experience in an Australian academic cancer center
W. Ong (2017)
10.3390/cancers8090084
Antibiotic Treatment in End-of-Life Cancer Patients—A Retrospective Observational Study at a Palliative Care Center in Sweden
Maria Helde-Frankling (2016)
10.21037/apm.2017.10.01
Supportive & palliative interventions in motor neurone disease: what we know from current literature?
Hon Wai Benjamin Cheng (2018)
10.1007/s00520-014-2489-4
Caring for terminal patients in haematology: the urgent need of a new research agenda
P. Niscola (2014)
10.1007/s11912-019-0832-0
Transfusion as a Palliative Strategy
Jay S. Raval (2019)
10.1177/1049909119896533
End-of-Life Trajectories of Patients With Hematological Malignancies and Patients With Advanced Solid Tumors Visiting the Emergency Department: The Need for a Proactive Integrated Care Approach
M. Verhoef (2019)
10.1007/978-1-4471-2837-3_19
Palliative Care in Elderly Patients with Hematological Malignancies
U. Wedding (2015)
10.1016/j.jiac.2020.07.017
Status and cost analysis of antimicrobial treatment of terminally ill patients with hematological malignancy in an acute hospital.
M. Chiba (2020)
10.5041/RMMJ.10182
Rituals in Death and Dying: Modern Medical Technologies Enter the Fray
M. Gordon (2015)
10.3978/j.issn.2224-5820.2013.12.02
End of life care in hematology: still a challenging concern.
P. Niscola (2014)
10.1136/bmjspcare-2014-000793
Preferred and actual place of death in haematological malignancy
D. Howell (2017)
10.1007/s00277-020-04386-8
Supportive and palliative care in hemato-oncology: how best to achieve seamless integration and subspecialty development?
Hon Wai Benjamin Cheng (2021)
Therapeutic Advances in Drug Safety Addressing the first Iatrogenic epidemic: the role of de-prescribing in polypharmacy and inappropriate medication use Special Collection
M. Juthani-mehta (2019)
10.1177/1049909119887951
Palliative Care for Patients With Hematologic Malignancies in a Low-Middle Income Country: Prevalence of Symptoms and the Need for Improving Quality of Attention at the End of Life
J. Jaime-Pérez (2019)
10.1007/s00520-014-2333-x
End-of-life characteristics and palliative care provision for elderly patients suffering from acute myeloid leukemia
Hon Wai Benjamin Cheng (2014)
10.1111/pme.12803
Successful Analgesic use of Ketamine Infusion in Malignant Cord Compression.
Hon Wai Benjamin Cheng (2015)
10.1111/vox.12986
Platelet transfusions in haematologic malignancies in the last six months of life.
Julie Moracchini (2020)
10.1177/1049909118806456
A Retrospective Chart Review of Transfusion Practices in the Palliative Care Unit Setting
G. Sirianni (2018)
10.1177/2042098618820210
Design and analysis of longitudinal trials of antimicrobial use at the end of life: to give or not to give?
M. Juthani-mehta (2019)
10.1136/bmjspcare-2020-002558
Antimicrobial use at the end of life: a scoping review
Jack Fairweather (2020)
10.1007/s00520-017-4023-y
Transfusion practices at end of life for hematopoietic stem cell transplant patients
Winnie S. Wang (2017)
10.1007/s00277-017-3045-3
Palliative home care for patients with advanced haematological malignancies—a multicenter survey
F. Kaiser (2017)
Atención paliativa en pacientes con neoplasias hematológicas: un nuevo modelo de atención basado en la evaluación precoz de necesidades.
Deborah Moreno Alonso (2018)
10.1016/j.bulcan.2020.08.007
Étude des représentations de la transfusion plaquettaire en fin de vie par ses acteurs : patients, infirmiers et médecins d’hématologie
Julie Moracchini (2020)
10.3978/j.issn.2224-5820.2013.12.01
Haematology and palliative medicine: moving forward.
P. Mcgrath (2014)
10.1016/j.ejon.2019.02.003
Haematology nurses' perspectives of their patients' places of care and death: A UK qualitative interview study
D. McCaughan (2019)
10.1016/j.jpainsymman.2015.01.008
Optimizing End-of-Life Care for Patients With Hematological Malignancy: Rethinking the Role of Palliative Care Collaboration.
H. Cheng (2015)
10.1136/bmjspcare-2020-002453
Haematological cancer versus solid tumour end-of-life care: a longitudinal data analysis
S. Yang (2020)
10.1186/s12885-017-3207-7
A systematic review of prognostic factors at the end of life for people with a hematological malignancy
Elise Button (2017)
10.1159/000495424
Palliative Care in Patients with Hematological Malignancies
K. Oechsle (2018)
10.1007/s00520-020-05638-z
Acute palliative care unit–initiated interventions for advanced cancer patients at the end of life: prediction of impending death based on Glasgow Prognostic Score
Yoshihide Nagasako (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar